Courtney A McKnight
Courtney A McKnight
Clinical Associate Professor of Epidemiology
-
Professional overview
-
Dr. Courtney McKnight is a Principal Investigator specializing in mixed methods research focused on the epidemiology of drug use, opioid overdose, HIV and HCV infection. Dr. McKnight has over 20 years of experience conducting public health research related to drug use, as well as field experience as a harm reduction service provider.
Prior to joining NYU, Dr. McKnight served as the assistant director of research at the Chemical Dependency Institute at the Icahn School of Medicine at Mount Sinai, where she was an investigator and project director on numerous federally funded research studies, including evaluations of syringe services programs; investigations of the drivers that contribute to disparate rates of HIV and HCV; and interventions to increase access to HIV and HCV testing and care.
Previous to Dr. McKnight’s work in research, she directed a harm reduction program for women who use drugs and volunteered at a syringe services program in New Jersey.
Dr. McKnight received her DrPH from the City University of New York Graduate Center, her Master of Public Health from Hunter College, and her Bachelor of Arts in sociology from Rutgers University. Her dissertation examined the impact of Medicaid coverage of methadone and buprenorphine on treatment access for opioid dependent beneficiaries.
Dr. McKnight’s current research interests include examining the shifting landscape of illicit opioids, including the increasing prevalence of illicitly manufactured fentanyl, and risk environments of people who use drugs.
-
Education
-
BA, Women's Studies, Rutgers University, New Brunswick, NJMPH, Community Health Education, Hunter College, New York, NYDrPH, The City University of New York, New York, NY
-
Areas of research and study
-
Behavioral ScienceDrug addictionEpidemiologyHarm reductionHepatitisHIV/AIDSInfectious DiseasesMixed-Methods ResearchOpioidQualitative ResearchSocial epidemiologySubstance Abuse
-
Publications
Publications
Long COVID as a Novel Illness Identity: Biographical Disruption, Contested Illness, and Stigma Processes.
Failed retrieving data.Anti-vaccine attitudes and COVID-19 vaccine status at the end of the U.S. public health emergency
Failed retrieving data.Engagement in hepatitis C virus cascade of care and factors associated with testing among people who inject drugs in Iran
Failed retrieving data.Harms associated with injecting in public spaces: a global systematic review and meta-analysis
Failed retrieving data.Heroin, Fentanyl, Intentional Fentanyl Use and HIV Transmission in a Community-Recruited Sample of Persons Who Inject Drugs, New York City: 2021-2023
Failed retrieving data.Naloxone Carrying Among People Who Inject Drugs in New York City
Failed retrieving data.COVID-19 vaccination uptake and determinants of booster vaccination among persons who inject drugs in New York City
Failed retrieving data.Facilitators and barriers to monitoring and evaluation at syringe service programs
Failed retrieving data.Hepatitis C treatment outcomes among people who inject drugs experiencing unstable versus stable housing : Systematic review and meta-analysis
Failed retrieving data.COVID-19 vaccination and HIV transmission among persons who inject drugs during the first two years of the COVID-19 pandemic in New York City
Failed retrieving data.COVID-19 Vaccination and HIV Transmission Among Persons who Inject Drugs During the First Two Years of the COVID-19 Pandemic in New York City.
Failed retrieving data.Factors associated with carrying naloxone among people who inject drugs in New York City.
Failed retrieving data.Field Testing the “Avoid the Needle” Intervention for Persons at Risk for Transitioning to Injecting Drug Use in Tallinn, Estonia and New York City, USA
Failed retrieving data.Global epidemiology of abortion among female sex workers : a systematic review, meta-analysis, and meta-regression
Failed retrieving data.HIV risk and prevention among clients of a delivery-based harm reduction service during an HIV outbreak among people who use drugs in northern rural Minnesota, USA
Failed retrieving data.HIV risk and prevention among clients of a delivery-based harm reduction service during an HIV outbreak among people who use drugs in northern rural Minnesota, USA
Failed retrieving data.Non-fatal drug overdose among persons who inject drugs during first two years of the COVID-19 pandemic in New York City : Prevalence, risk factors
Failed retrieving data.Non-fatal drug overdose among persons who inject drugs during first two years of the COVID-19 pandemic in New York City: prevalence, risk.
Failed retrieving data.Research with People Who Use Drugs: Methods and Ethical Considerations for Survey Design.
Failed retrieving data.Understanding intentionality of fentanyl use and drug overdose risk : Findings from a mixed methods study of people who inject drugs in New York City
Failed retrieving data.Understanding known and unknown fentanyl use: a mixed methods examination of drug overdose risk among people who inject drugs (PWID) during a spike in fatal drug overdose.
Failed retrieving data.Understanding perceptions and intentionality of fentanyl use: a mixed methods examination of drug overdose risk.
Failed retrieving data.Modeling HIV transmission among persons who inject drugs (PWID) at the “End of the HIV Epidemic” and during the COVID-19 pandemic
Failed retrieving data.Recurrent Injecting Drug Use as a Mediator between Psychiatric Disorder and Non-Fatal Overdose
Failed retrieving data.Thick trust, thin trust, social capital, and health outcomes among trans women of color in New York City
Failed retrieving data.